Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter A. Thompson Insider Profile
11 Followers
Peter A. Thompson, Director at Adaptimmune Therapeutics, holds 8.29M shares in ARS Pharmaceuticals (Ticker: SPRY), holds 0.00 shares in Alpine Immune Sciences (Ticker: ALPN), holds 14.76M shares in Edgewise Therapeutics (Ticker: EWTX). Most recently, Peter A. Thompson Sold ― shares of ARS Pharmaceuticals on Aug 28, 2024 for an estimated value of 1.09M.
Peter A. Thompson Adaptimmune Therapeutics (ADAP)Director
Adaptimmune Therapeutics (ADAP)
Director
Ranked #3,968 out of 99,218 Corporate Insiders
Profitable Transactions
16 out of 29 Profitable Transactions
Average Return
+17.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Peter A. Thompson holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 28, 2017 - Mar 28, 2018
Return:+128.10%
The most profitable trade made by Peter A. Thompson
Peter A. Thompson's Trading History
Adaptimmune Therapeutics
Jun 06, 2018
Director
Informative Sell
253.63K
$3.90M
Alpine Immune Sciences
May 20, 2024
―
Uninformative Sell
―
$0.00
Corvus Pharmaceuticals
Sep 22, 2021
Director, Ten Percent Owner
Informative Sell
6.76M
$65.62M
Thoratec Corp
Dec 13, 2018
―
Uninformative Buy
―
$337.59M
Synthorx
Jan 24, 2020
―
Uninformative Sell
361.51M
$0.00
Prevail Therapeutics
Jun 26, 2019
―
Uninformative Buy
―
$317.92M
PMV Pharmaceuticals
Sep 29, 2020
Director, Ten Percent Owner
Uninformative Buy
―
$198.43K
ARS Pharmaceuticals
Aug 28, 2024
Director
Informative Sell
1.09M
$141.24M
Decibel Therapeutics
Feb 19, 2021
―
Uninformative Buy
―
$4.34M
Edgewise Therapeutics
Jan 25, 2024
Director, Ten Percent Owner
Informative Buy
5.00M
$536.83M
Janux Therapeutics Inc
Dec 30, 2021
Director
Informative Sell
820.12K
$12.46M
Anthera Pharmaceuticals
―
Director
―
$0.00
Mirati Therapeutics
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Peter A. Thompson's performance on stock
You May Also Like
Peter A. Thompson insider profile FAQ
What is the percentage of profitable transactions made by Peter A. Thompson?
The percentage of profitable transactions made by Peter A. Thompson is 55%.
What is the average return per transaction made by Peter A. Thompson?
The average return per transaction made by Peter A. Thompson is 17.70%.
What stocks does Peter A. Thompson hold?
Peter A. Thompson holds: ADAP, ALPN, CRVS, ~THOR, THOR, PRVL, PMVP, SPRY, DBTX, EWTX, JANX, ANTH, MRTX stocks.
What was Peter A. Thompson’s latest transaction?
Peter A. Thompson latest transaction was an Informative Sell of $1.09M.
What was Peter A. Thompson's most profitable transaction?
Peter A. Thompson’s most profitable transaction was an Informative Buy of ADAP stock on March 28, 2017. The return on the trade was 128.10%.
What is Peter A. Thompson's role in Adaptimmune Therapeutics?
Peter A. Thompson's role in Adaptimmune Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.